Spebrutinib (CC-292)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 17:56, 3 February 2019 by Warner-admin (talk | contribs) (Text replacement - "Category:Chemotherapy" to "Category:Chemotherapeutic")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Bruton's tyrosine kinase (BTK) inhibitor

Also known as

Code names: AVL-292, CC-292

Retrieved from "https://hemonc.org/w/index.php?title=Spebrutinib_(CC-292)&oldid=35493"